baber/WOPTO huggingface dataset:
Patent NZ-228633-A (NZ)
Title: Ski rope winch and boat attachment device avoiding use of tools
Inventor: SEHL DOUGLAS
IPC: B63B35/81
Filed: 1989-04-06
Abstract: A device (10) for winding and unwinding a waterski tow-line (21) comprises a substantially enclosed housing (20) having a spool mounted for rotation in the housing. A driven gear is mounted on the spool (22) for rotational driving thereof. A drive shaft is journaled in the housing for rotation and for axial sliding relative to the housing and the drive shaft (28) has a first end portion protruding from the housing and a second end portion extending into the housing. A drive gear (26) is rigidly affixed to the drive shaft for rotation and for axial sliding with it. A spring (36) is mounted in the housing to bias the drive gear (34) into meshing engagement with the driven gear (26). A crank lever (38) is pivotally connected to the second end portion (32) of the drive shaft by an eccentrically positioned pivot pin (46). With this arrangement, upon pivoting movement of the crank lever (38) to a first orientation generally transverse to the axle of the drive shaft (28), the yoke portion (48) urgingly contacts the housing so as to cause axial sliding of the drive shaft (28) in a first axial direction against biasing of the spring (36), so as to cause disengagement of the drive gear (34) from the driven gear (26), thereby allowing free rotation of the spool (22), and consequential unwinding of the tow-line therefrom. On pivoting movement of the crank lever to a second orientation 180 DEG  opposite to the first orientation, the yoke portion (48) is removed from urging contact with the housing (20) so as to allow the drive shaft (28) to slide in an axially opposite second direction under biasing of the spring (36), so as to cause engagement of the drive gear (34) with the driven gear (26), thereby allowing for controlled rotation of the spool (22) upon rotation of the crank lever (38), so as to wind the tow-line (21) around the spool (22).
Patent NZ-229206-A (NZ)
Title: Hybrid-dna molecule from s. dysgalactiae coding for a protein or peptide with fibronectin binding properties
Inventor: HOOK MAGNUS
IPC: A61P31/04
Filed: 1989-05-19
Abstract: The present invention relates to new recombinant DNA-molecules comprising nucleotide sequences of S. dysgalactiae encoding for at least one protein or polypeptide having fibronectin binding property.
Patent NZ-237187-A (NZ)
Title: Condensed thiazole derivatives and pharmaceutical compositions containing them
Inventor: TETSUYA AONO
IPC: C07D513/04
Filed: 1991-02-21
Abstract: A novel condensed thiazole derivative of the formula [I]: <CHEM> wherein A is a single bond or CH2; R<1> is hydrogen atom, or an optionally substituted aliphatic, carboxylic acyl or sulfonic acyl group; and R<2> is hydrogen atom, or an optionally substituted aromatic cyclic or aliphatic group, or a salt thereof. The compound [I] is useful for medicines for preventing and treating various diseases such as cancer, arterial sclerosis, hepatopathy, cerebrovascular diseases, inflammatory and the like. A process of the compound of the formula [I] or a salt thereof and a pharmaceutical composition comprising the compound of the formula [I] or a pharmaceutically acceptable salt thereof as an active component are also disclosed.
Patent NZ-239044-A (NZ)
Title: Decontaminating metal scrap contaminated with organic material by heating in a fluidised bed at a temperature below the melting point of the metal
Inventor: DUBE GHYSLAIN
IPC: C23G5/00
Filed: 1991-07-19
Abstract: PCT No. PCT/CA91/00252 Sec. 371 Date Jan. 4, 1993 Sec. 102(e) Date Jan. 4, 1993 PCT Filed Jul. 18, 1991 PCT Pub. No. WO92/01825 PCT Pub. Date Feb. 6, 1992.The invention relates to a process of decontaminating metal (especially aluminum or aluminum alloy) scrap contaminated with organic material. The problem with such methods is that undue oxidation of the metal may take place as the decontamination proceeds, leading to reduced recovery rates. The process involves heating the scrap in a fluidized bed of solid particles fluidized by a fluidizing gas to a decontaminating temperature high enough to consume the organic material but below the melting point of the metal. The heating step is carried out in the presence of a protective material which protects the aluminum or aluminum alloy against substantial oxidation while the scrap is held in the bed at the decontaminating temperature. Preferred protective materials include organic and inorganic fluorine-containing compounds, particularly AIF3. The process is particularly effective for the treatment of aluminum alloys containing magnesium, which are especially susceptible to oxidation. Scrap decontaminated in this way can be subjected to conventional metal recovery processes, e.g. metal melting, and provide high recovery rates of the metal. The process of the invention can also be used for protecting metal (particularly aluminum and alloys thereof) against excessive oxidation during heat treatments other than decontamination. The invention also relates to the treatment of briquettes of compacted scrap without the need for protection from oxidation and without the need for prior shredding or grinding.
Patent NZ-331674-A (NZ)
Title: Use of antigenic preparations comprising Helicobacter catalase for treating or preventing Helicobacter infection
Inventor: DOIDGE CHRISTOPHER VINCENT
IPC: A61K39/40
Filed: 1995-06-08
Abstract: Use of Helicobactor pylori or Helicobactor felis catalase enzyme in the treatment of Helicobactor infection.
Patent NZ-336229-A (NZ)
Title: Coating blade comprising a steel band having a wear-resistant coating, e.g. of an organic polymer, with a Shore A hardness of from 10 to 100
Inventor: ERIKSSON TORE
IPC: B05C9/04
Filed: 1997-12-16
Abstract: A coating blade for applying coating material onto a travelling web 41, particularly coating liquid onto a travelling paper web, comprises a steel band 3, which, along the edge section intended to engage web 41, is provided with a wear-resistant coating 5.  Coating 5 is constituted by a material which has a hardness according to Shore A of from about 10 to about 100.  Apparatus for coating of web 41 may comprise means to carry and transport the web, two opposite coating blades 29, 31 and pressure means (not shown) arranged so that each blade to brought to engage the web forwarded between the blades.  The coating material may be polyurethane.
Patent NZ-338018-A (NZ)
Title: Transmitting IP packet over fibre optic network using return to zero (RZ) encoding
Inventor: SAUNDERS ROSS ALEXANDER
IPC: H04B10/556
Filed: 1999-09-24
Abstract: An embodiment includes an optical source, an optical receiver, and an interconnecting optical fiber. A data sequence is received and encoded or formatted as an IP packet using an encoding format capable of returning a signal representing the IP packet to a predetermined value at the beginning of each bit period of the IP packet at a physical layer of the network. The encoded IP packet is then transmitted directly over an optical layer of the network without adapting the IP packet to another encoding format or using an adaptation layer in the network (e.g., at a data link layer or higher). The optical receiver receives the IP packet and then a clock signal is extracted without the overhead and costs associated with additional adaptation or encoding of the IP packet. When the optical source is in an idle state, a mark-hold state (more generally called a filler signal) is formatted with the same encoding format and transmitted to the optical receiver directly over the optical layer in order to maintain a synchronous clock during the idle state. <IMAGE>
Patent NZ-503882-A (NZ)
Title: Artificial intelligence system comprising a neural network with an adaptive component arranged to aggregate rule nodes
Inventor: KASABOV NIKOLA KIRILOV
IPC: G06N3/04
Filed: 2000-04-10
Abstract: The neural network module comprises an input layer (40), a rule base layer (46), fuzzy layers (44,48) and an output layer (56). Within each layer, nodes are provided for input/output of data, such as input nodes (42) and rule layer nodes (50). The fuzzy input layer (44) converts inputs into membership degrees to which the input values belong. The rule based layer nodes (50) decide how the input would affect the output and is activated if the input exceeds a minimum activation threshold. The neural network also has an adaptation component that aggregates selected two or mote nodes within the rule base layer depending on the input data, and to increase the minimum activation threshold of the nodes that were not selected for aggregation. This makes the non-selected nodes less "sensitive" and will prevent future misclassification.
Patent NZ-506096-A (NZ)
Title: 1,2,4,5-Tetrahydro-benzo[d]azepines
Inventor: ADAM GEO
IPC: A61P25/24
Filed: 2000-08-01
Abstract: Compounds of the general formula 1 are described wherein n is 1-6; X signifies -N=, =N-, -N<, >C= or =C<; Y signifies -N=, =N-, -NH, CH= or =CH; and the dotted line may be a double bond; R1 is H, alkyl, O, halogen, -ORa, -SRb, -NRc; R2 signifies nitro or cyano; R3 signifies hydrogen, lower alkyl, =O, =S, -SR, -S(O)2-lower alkyl, -(C3-C6)cycloalkyl or piperazino, optionally substituted by lower alkyl, or -CONR2, -(CHR)nCONR2, -(CHR)nOR, -(CH2)n-CF3, -CF3, -(CHR)nOC(O)CF3, -(CHR)nCOOR, optionally substituted -(CHR)nSC6H5, -(CHR)n-1,3-dioxo-1,3-dihydro-isoindol, -(CHR)n-tetrahydro-pyran-2-yloxy or -(CHR)n-S-lower alkyl, or -NRd, or -ORe; and R4 signifies hydrogen, lower alkyl, lower alkenyl or nitro, or -ORf, or -(CHR)nCHRF, -(CHR)nCF2R, -(CHR)nCF3, -(C3-C6)cycloalkyl, -(CHR)n(C3-C6)cycloalkyl, -(CHR)nCN, optionally substituted -(CHR)n-phenyl, -(CHR)(CHR)nOR, -(CHR)nCHORCH2OR, -(CHR)(CHR)nNR2, -(CHR)nCOOR, -(CHR)(CHR)nOSi-lower alkyl, -(CHR)(CHR)n-OS(O)2-lower alkyl, -(CH2)n-CH=CF2 -CF3, -CF2-R2, -CF2-lower alkenyl. -CHRF, -CHF-lower alkyl, -CF2-lower alkenyl, -CHRF, -CHF-lower alkenyl, -(CHR)n-2,2-dimethyl-[1,3]dioxolane, -(CH2)-2-oxo-azepan-1-yl, -(CHR)(CHR)n-morpholine, -(CHR)n-pyridino, -(CHR)(CHR)n-imidazolo, -(CHR)(CHR)n-triazolo, -(CHR)(CHR)­-pyrrolidino, optionally substituted by -(CH2)nOH, -(CHR)(CHR)n-3-hydroxy-pyrrolidino or -(CHR)(CHR)n-piperidino, or -NRg; or is absent, if X is -N= or =N-; or R4 and R1 or R3 and R4 are interconnected to form the groups -(CH2)3-5, -(CH2)2-N=, -CH=N-N=-, -CH=CH-N=, -NH-CH=CH- or -NR-CH2-CH2- and form together with the N and C atoms to which they are attached an additional ring; R5 and R6 signify hydrogen, lower alkyl, lower alkoxy, amino, nitro, -SO2NH2 or halogen; or are interconnected to form the group -O-CH2-O- and form together with the C atoms to which they are attached an additional 5-membered ring; R7, R8 signify hydrogen, lower alkyl, lower alkoxy, amino, nitro or halogen; R9, R10 signify hydrogen, lower alkyl; R11, R12 signify hydrogen, lower alkyl, hydroxy, lower alkoxy, lower alkoxycarbonyloxy or lower alkanoyloxy; R13, R14 signify hydrogen, tritium or lower alkyl; R15, R16 signify hydrogen, tritium, lower alkyl, hydroxy, lower alkoxy, lower alkoxycarbonyloxy or lower alkanoyloxy; or are together an oxo group.
Patent NZ-510072-A (NZ)
Title: Adult-infant bonding garment in the form of blouse with pouch at the front for skin to skin contact
Inventor: SHATZKIN ELLEN
IPC: A41D1/215
Filed: 1999-07-19
Abstract: An article of clothing such as a shirt or blouse is disclosed which allows for skin to skin contact between a person and infant and which includes a pouch or pouches on the inside of the shirt centrally located thereon in which the infant may be placed. A larger pouch for a more developed infant may also be provided.
Patent NZ-513624-A (NZ)
Title: Gaming systems and methods
Inventor: SZEWACH ELIK
IPC: G06Q30/00
Filed: 2000-03-27
Abstract: A wagering gaming system having a player playing against a casino and/or against one or more other players includes: a player-chip card (such as a smart card) providing access to the game, with the player-chip-card including an electronic player purse and memory for pre-recording biometric data characteristics of the player as an individual and a player card interface which includes means for reading biometric data from the player at the time of intended player access to the game so that access to the game is conditional upon computer-mediated matching of biometric data derived from the player with said pre-recorded biometric data. The player card interface is computer based and includes a receiving, displaying and transmitting means and also allows monetary transactions to be effected using the electronic player purse following access to the game. The player card interface reads the amount of the monetary value within the electronic player purse in the player-chip- card in the player-card interface and transfers monetary values to or from the electronic player purse upon input by the player to place bets or return wins following the computer-mediated matching of biometric data. The player-card interface is interconnected with other similar player-card interfaces of the other players via a telecommunication link, which permits communication between multiple players. The player is able to effect monetary transactions including placing monetary bets, paying monetary losses and collecting monetary wins according to the rules of a wagering game.
Patent NZ-520982-A (NZ)
Title: Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
Inventor: AL-OBEIDI FAHAD
IPC: C07C257/18
Filed: 2001-02-21
Abstract: Antithrombotic compounds of formula (I), the preparation thereof, and the therapeutic use thereof as inhibitors of blood-clotting enzyme factor Xa.
Patent NZ-522417-A (NZ)
Title: Dynamic series voltage compensator and method thereof
Inventor: CORNICK KEITH JOSEPH
IPC: G05F1/70
Filed: 2000-04-25
Abstract: A dynamic series voltage compensator (10) for compensating voltage dips in an ac electric power system is described. The compensator (10) has a controller (11) coupled to control a respective series injection inverter (12a, 12b, 12c). The controller (11) monitors a supply voltage with/on a respective phase. Inputs from monitoring the supply voltage are processed by the controller (11) to generate control signals. These control signals are based on comparing voltage magnitude of a present voltage cycle period with voltage magnitude of a preceding voltage cycle period of the supply voltage. When difference between the present and the preceding voltage cycle periods exceed a predetermined value for a corresponding time period, and inverter control signal is provided to the respective series injection inverter (12a, 12b, 12c) to thereby provide a compensation voltage. The compensation voltage is injected directly to the respective conductor. The voltage magnitude of the compensation voltage is to compensate the supply voltage to a normal level based on the preceding voltage cycle period.
Patent NZ-523195-A (NZ)
Title: Antibodies to human MCP-1
Inventor: HIESTAND PETER
IPC: A61P35/00
Filed: 2001-06-29
Abstract: Disclosed is a MCP-1 binding molecule which comprises: an antigen binding site with at least one immunoglobulin heavy chain variable domain (VH) which includes in sequence hypervariable regions CDR1, CDR2 and CDR3. CDR1 has the amino acid sequence His-Tyr-Trp-Met-Ser, CDR2 has the amino acid sequence Asn-Ile-Glu-Gln-Asp-Gly-Ser-Glu-Lys-Tyr-Tyr-Val-Asp-Ser-Val-Lys-Gly, and CDR3 has the amino acid sequence Asp-Leu-Glu-Gly-Leu-His-Gly-Asp-Gly-Tyr-Phe-Asp-Leu; and/or can comprise an antigen binding site with at least one immunoglobulin light chain variable domain (VL) which includes in sequence hypervariable regions CDR1', CDR2' and CDR3', said CDR1' having the amino acid sequence Arg-Ala-Ser-Gln-Gly-Val-Ser-Ser-Ala-Leu-Ala, said CDR2' having the amino acid sequence Asp-Ala-Ser-Ser-Leu-Glu-Ser, and said CDR3' having the amino acid sequence Gln-Gln-Phe-Asn-Ser-Tyr-Pro; and direct equivalents. Also disclosed are specific amino acid sequences that the MCP-1 binding molecule may have, DNA constructs that encode the molecule, methods of their production and their use as a medicament for the treatment of an MCP-1- or eotaxin-medicated disease or disorder.
Patent NZ-530368-A (NZ)
Title: Use of thiazole derivatives for preparing a medicine for protecting mitochondria
Inventor: AUGUET MICHEL
IPC: A61P21/00
Filed: 2002-07-25
Abstract: The use of thiazole derivatives of general formula (I) for preparing a medicament intended to protect the mitochondria, and in particular to prevent or treat cirrhosis of the liver is disclosed.
Patent NZ-532487-A (NZ)
Title: Medical device having releasable retainer
Inventor: CAIZZA RICHARD J
IPC: A61B17/20
Filed: 2004-04-22
Abstract: A medical device having a releasable retaining includes needle cannula (21) connected to a hub (31) having an open proximal end with a frusto-conically shaped cavity therein. The cavity is part of a passageway (35) through the hub (31) which is in fluid communication with the lumen (24) of the needle cannula (21). A retaining element (41) is releasably connected to the hub (31). The element (41) includes an aperture and at least one protuberance (typically part of the retaining element (41)) projecting into the aperture for engaging the frusto-conically shaped tip of a fluid delivery device (51). The protuberance is shaped to offer less resistance to hub (31) movement in a direction of engagement than in a direction of disengagement with the tip. The retaining element is connected to the hub (31) so that when the hub (31) is engaged to the tip, the force required to disengage the retaining element (41) from the tip is greater than the force required to disengage the retaining element (41) from the hub (31).
Patent NZ-533473-A (NZ)
Title: Benzothiazine and benzothiadiazine compounds, pharmaceutical compositions and preparation process thereof
Inventor: DESOS PATRICE
IPC: A61P43/00
Filed: 2004-06-11
Abstract: Benzothiazine and benzothiadiazine compounds of formula (I), their isomers and addition salts pharmaceutical compositions, and preparation process thereof are disclosed, wherein: R1 represents an heterocyclic group; R2 represents hydrogen, halogen or a hydroxy; A represents CR4R5 or NR4; R3 represents hydrogen, a linear or branched (C1-C6)alkyl or a (C1-C6)cycloalkyl group; R4 represents hydrogen or a linear or branched (C1-C6)alkyl group; or A represents a nitrogen and together with the adjacent -CHR3- group, forms the ring as defined in the specification; and R5 represents hydrogen or halogen. These benzothiazine and benzothiadiazine compounds of formula (I) are useful as AMPA modulators.
Patent NZ-534269-A (NZ)
Title: Antibodies to human IL-1beta
Inventor: GRAM HERMANN
IPC: A61P31/04
Filed: 2001-08-20
Abstract: Disclosed is an IL-1beta binding molecule which comprises an antigen binding site comprising no immunoglobulin light chain variable domain (VL) but at least one immunoglobulin heavy chain variable domain (VH) which comprises in sequence hypervariable regions CDR1, CDR2, CDR3, said CDR1 having the amino acid sequence Val-Tyr-Gly-Met-Asn-, said CDR2 having the amino acid sequence Ile-Ile-Trp-Tyr-Asp-Gly-Asp-Asn-Gln-Tyr-Tyr-Ala-Asp-Ser-Val-Lys-Gly, said CDR3 having the amino acid sequence Asp-Leu-Arg-Thr-Gly-Pro; and direct equivalents thereof Further disclosed is a process for the production of the binding molecule and a pharmaceutical composition comprising the antibody to IL-1beta. I(62) Divided Out of 524199
Patent NZ-541063-A (NZ)
Title: ME-5, ME-2, and EPP2: human protein antigens reactive with autoantibodies present in the serum of women suffering from endometriosis
Inventor: EL SHAMI A SAID
Filed: 2005-06-30
Abstract: Disclosed is a method of detecting the presence of endometriosis by detection of antibodies that bind to ME-5, ME-2 or EPP2 polypeptides or epitopes thereof. Also disclosed is a method for capturing antibodies that bind abovementioned polypeptides and analysis of said antibodies.
Patent NZ-544456-A (NZ)
Title: Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin
Inventor: OFT MARTIN
IPC: C12N5/09
Filed: 2004-07-16
Abstract: Provided is the use of Thymic Stromal Lymphopoietin (TSLP) or and agonistic antibody thereof for the preparation of a medicament for treating or preventing neoplasms. Further provided is the use of the said compositions in an in vitro method of diagnosis for neoplasms, including also the use of anti-TSLPR antibody.
Patent NZ-547686-A (NZ)
Title: Lift installation with a support means end connection and a support means, and a method of fastening an end of a support means in a lift installation
Inventor: DOLD FLORIAN
Filed: 2006-06-01
Abstract: In an elevator installation, an apparatus and a method use a support end connection for fastening a support device to an elevator car, a counterweight and/or a building. The support device has at least one cable or cable strand enclosed by a cable casing and is held in a wedge pocket by a wedge. The cable casing is formed of thermoplastic material or an elastomer and at least one of a region of the wedge or the wedge pocket is provided with a longitudinal wedge groove and a region of the wedge, of the wedge pocket or the cable casing has a reduced coefficient of friction. The support device is preferably a multiple cable.
Patent NZ-548477-A (NZ)
Title: Electrical link disconnect device
Inventor: OGDEN BRUCE JAMES
Filed: 2006-07-12
Abstract: An electrical link disconnect device (1), for connecting two electrical cable terminals, each having opposing conductive surfaces, is disclosed. The device comprises a housing (2), a first conductive element (3) mounted in the housing (2), a second conductive element (4) mounted in the housing (2), opposing the first conductive element (3); and a locking element (5) hingedly connected to the housing (2) and operable between an unlocking position and a locking position, at which the locking element (5) is wedged between the first and second conductive elements (3, 4), driving the first and second conductive elements (3, 4) apart for forcibly engaging the first and second conductive elements (3, 4) with respective opposing conductive surfaces of each of two electrical terminals.
Patent NZ-554151-A (NZ)
Title: Less invasive surgical system and methods for spinal fixation
Inventor: GERBER DAVID
IPC: A61B17/88
Filed: 2005-09-28
Abstract: A system for performing a less invasive surgical procedure and, in particular, devices and methods for spinal fixation. The system comprises dilation tool(s), at least one working/insertion cannula, a plurality of screws, at least one fixation rod for connecting the screws, and a rod inserter. The dilation tool(s) may be used to dilate an incision made in a patient to form an opening. Thereafter, a drill may be used to form holes in the vertebrae. An insertion cannula may be attached to a screw and inserted into the opening. The screws may be polyaxial screws and may be inserted into the vertebrae using a screwdriver. An operator may then move the insertion cannula to manipulate a head portions of the screws such that the head portions may be aligned to receive a fixation rod. A rod inserter may be used to insert a fixation rod into the head portions.; After the fixation rod is in place, it may be locked to the screws, thereby fixing the system in place on the spine.
Patent NZ-560979-A (NZ)
Title: Selective direction of air in roof space out of or into the building
Inventor: OATEN TERRANCE ROBERT
IPC: E04B7/18
Filed: 2006-02-06
Abstract: A roof assembly for a building which includes a roof, a roof space 2 in heat exchange relationship with a section 8 of the roof, a chamber 3 placed on the roof and fans 15 for causing airflow within the roof space 2. The chamber has one or more first openings 5 that allow airflow from within the roof space to outside the building to cool the building, and one or more second openings 7 that allow air flow from the roof space 2 to a living space of the building. Airflow is controlled by selectively opening and closing the first and second openings.